To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Leukocyte-poor PRP may improve outcomes following arthroscopy for knee osteoarthritis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
October 2015

Leukocyte-poor PRP may improve outcomes following arthroscopy for knee osteoarthritis

Vol: 4| Issue: 10| Number:47| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:2

Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double-blind trial

Arch Orthop Trauma Surg. 2015 Jul;135(7):971-7.

Contributing Authors:
C Duif T Vogel F Topcuoglu G Spyrou C von Schulze Pellengahr M Lahner

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Fifty eight patients with osteoarthritis (OA) were randomized to receive arthroscopic treatment with or without intra-operative leukocyte-poor platelet-rich plasma (LP-PRP) injection. The goal of this study was to determine if there were any benefits to the added PRP intervention in terms of pain, function, or quality of life. The primary outcome of interest was pain as measured at 6 months after...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue